Submit Deal

SYNTHON INTERNATIONAL

HQ - Nijmegen

Summary

Synthon International produces and distributes pharmaceutical products. The Company offers biopharmaceutical products for genetic disorders and oncology. Synthon International markets its products worldwide.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 1.66 B

Avg. Deal Size£ 1.66 B

Market Context

Parent Company

SYNTHON HOLDING

2 transactions

Senior Management

Anish Mehta
CEO

Sort

02 Jul 2019|Netherlands|Pharmaceuticals

Target: SYNTHON INTERNATIONAL

Bidder: BC PARTNERS

11 Service Providers

8 Bidder | 3 Vendor

17 Dealmakers

10 Bidder | 7 Vendor

n/a

Value

16 Dec 2024|Netherlands|Pharmaceuticals

Target: SYNTHON INTERNATIONAL

Bidder: GOLDMAN SACHS ASSET MANAGEMENT

18 Service Providers

4 Target | 9 Bidder | 5 Vendor

88 Dealmakers

2 Target | 28 Bidder | 58 Vendor

£ 1.66 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy